SRF’s persistent pain point hampers investors’ confidence on earnings outlook

The management reiterated its 15-20% revenue growth guidance for the chemicals business and expects to deliver at the higher end of the range in FY27

Khabar Adda curates headlines like this across Top Stories, Entertainment, Bollywood, Hollywood, Crime and Politics from public RSS feeds. This page links out to livemint.com's own reporting rather than reproducing it — the excerpt above comes from livemint.com's own feed.